Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2013-06-12 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FONDETTES (37230), Indre-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES HAUTES ROCHES : revenue, balance sheet and financial ratios
PHARMACIE DES HAUTES ROCHES is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FONDETTES (37230),
this company of category PME
shows in 2025 a net income positive of 56 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES HAUTES ROCHES (SIREN 793653460)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
56 432 €
25 899 €
55 920 €
91 762 €
33 183 €
-18 086 €
2 529 €
-43 534 €
-23 766 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES HAUTES ROCHES generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
56 432 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
23.451%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.657%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES HAUTES ROCHES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
117.642
180.696
162.274
269.562
185.943
105.191
71.842
50.268
23.451
Financial autonomy
37.169
28.208
29.475
23.192
28.919
39.983
48.137
52.033
64.657
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
23.452025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-19 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES HAUTES ROCHES (23.45) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.66%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+15 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES HAUTES ROCHES (64.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
164.782
Liquidity indicators evolution PHARMACIE DES HAUTES ROCHES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
150.028
137.313
120.776
262.802
212.284
220.801
212.96
172.612
164.782
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
164.782025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-16 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DES HAUTES ROCHES (164.78) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DES HAUTES ROCHES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES HAUTES ROCHES is estimated at
896 429 €
(range 608 320€ - 1 406 620€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
608k€896k€1406k€
896 429 €Range: 608 320€ - 1 406 620€
NAF 5 année 2025
Valuation method used
Net Income Multiple
56 432 €
×
15.9x
=896 429 €
Range: 608 321€ - 1 406 621€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES HAUTES ROCHES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES HAUTES ROCHES
What is the revenue of PHARMACIE DES HAUTES ROCHES ?
The revenue of PHARMACIE DES HAUTES ROCHES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES HAUTES ROCHES profitable?
Yes, PHARMACIE DES HAUTES ROCHES generated a net profit of 56 k€ in 2025.
Where is the headquarters of PHARMACIE DES HAUTES ROCHES ?
The headquarters of PHARMACIE DES HAUTES ROCHES is located in FONDETTES (37230), in the department Indre-et-Loire.
Where to find the tax return of PHARMACIE DES HAUTES ROCHES ?
The tax return of PHARMACIE DES HAUTES ROCHES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES HAUTES ROCHES operate?
PHARMACIE DES HAUTES ROCHES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart